MEI Pharma Inc banner

MEI Pharma Inc
NASDAQ:MEIP

Watchlist Manager
MEI Pharma Inc Logo
MEI Pharma Inc
NASDAQ:MEIP
Watchlist
Price: 3.07 USD 10.43% Market Closed
Market Cap: $100.8m

Balance Sheet

Balance Sheet Decomposition
MEI Pharma Inc

Balance Sheet
MEI Pharma Inc

Rotate your device to view
Balance Sheet
Currency: USD
Jun-2015 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2021 Jun-2022 Jun-2023 Jun-2024
Assets
Cash & Cash Equivalents
19
11
9
13
10
12
9
16
17
4
Cash Equivalents
19
11
9
13
10
12
9
16
17
4
Short-Term Investments
45
35
45
89
65
170
145
138
84
35
Total Receivables
0
0
0
0
6
23
8
10
0
0
Accounts Receivables
0
0
0
0
1
3
8
10
0
0
Other Receivables
0
0
0
0
5
20
0
0
0
0
Other Current Assets
1
1
2
2
2
3
4
4
7
2
Total Current Assets
64
47
55
104
82
209
165
167
108
41
PP&E Net
0
0
0
0
0
1
9
11
13
1
PP&E Gross
0
0
0
0
0
1
9
11
13
1
Accumulated Depreciation
0
0
0
0
0
0
0
1
1
2
Intangible Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
65
N/A
47
-27%
56
+18%
105
+88%
83
-21%
210
+154%
174
-17%
178
+2%
121
-32%
41
-66%
Liabilities
Accounts Payable
1
1
1
4
5
2
6
8
6
3
Accrued Liabilities
4
4
3
4
5
6
9
12
14
5
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
1
1
5
5
5
5
0
0
Total Current Liabilities
5
6
5
8
14
14
20
24
20
8
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
46
20
119
104
101
76
0
Total Liabilities
5
N/A
6
+10%
5
-11%
54
+1 006%
35
-36%
133
+282%
125
-6%
125
+1%
96
-23%
8
-91%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
156
177
174
214
231
278
320
374
406
388
Additional Paid In Capital
216
219
225
265
279
356
369
427
431
421
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
60
N/A
42
-30%
51
+22%
51
-1%
48
-5%
77
+61%
50
-36%
52
+6%
25
-53%
33
+34%
Total Liabilities & Equity
65
N/A
47
-27%
56
+18%
105
+88%
83
-21%
210
+154%
174
-17%
178
+2%
121
-32%
41
-66%
Shares Outstanding
Common Shares Outstanding
2
2
2
4
4
6
6
7
7
7
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett